All authors Continuant Continuant Entity Entity Independent Continuant Agent Institute research investigator 2025-05-06T13:36:59 RDF description of McEvoy, Charlene E., MD, MPH - http://repository.healthpartners.com/individual/person-McEvoy-C-E Regions Hospital Sr. Investigator /care/find/doctor/8643/ /institute/wp-content/uploads/2018/01/McEvoy.Charlene_CV.pdf McEvoy, Charlene E., MD, MPH person-McEvoy-C person-McEvoy-C-E- person-McEvoy-C-E <p><strong>Title: </strong>Clinical investigator; staff physician, Pulmonary Critical Care Department, Regions Hospital; medical director, Hudson Hospital Sleep Lab, Hudson, WI; medical director, Asthma Center, 开云体育 Specialty Center, St. Paul, MN; medical director, Regions Hospital/开云体育 Sleep Center, Maplewood, MN; medical director, Regions/开云体育 Home Medical Equipment, St. Paul.</p> <p>Assistant professor of medicine, University of Minnesota, Minneapolis.</p> <p><strong>Education and training: </strong>MD, MPH, University of Minnesota; Residency in internal medicine, University of Minnesota Medical School, Minneapolis; Chief medical resident, Ramsey Medical Center, St. Paul, MN; Fellowship in pulmonary and critical care medicine, University of Minnesota Medical School, Minneapolis; Fellowship in allergy, University of Minnesota Medical School, Minneapolis; Archibald Bush Medical Fellowship, Bush Foundation.</p> <p><strong>Overview/research interests:</strong> Dr. McEvoy鈥檚 research interests include COPD and other smoking-related disorders, asthma and sleep disorders.</p> <p><strong>Current projects:</strong></p> <ul> <li>COPD Gene Renewal. Funder: National Heart, Lung and Blood Institute</li> <li>A MultiCentre, Randomized, Double-blind, Parallel Group, Placebo-Controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) Added to High-Dose Inhaled Corticosteroid Plus Long-Acting 尾2 Agonist in Patients with Uncontrolled Asthma (SIROCCO) and (BORA 鈥� open label). Funder: AstraZeneca Pharmaceuticals</li> <li>A Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects with Asthma (AUSTRI TRIAL). Funder: GlaxoSmithKline</li> <li>A 24-Week Randomized Double-Blind Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of 18 MCG of Tiotropium Inhalation Capsules Administtered by Handihaler Once-Daily Plus PRN Albuteral (Salbutamol) vs. Placebo Plus PRN Albuterol (Salbutomol) in Chronic Obstructive Pulmonary Disease Subjects Na茂ve to Maintenance Therapy (SPIRIVA). Funder: Pfizer Inc., U.S. Pharmaceuticals Group</li> <li>Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma (PAS2). Funder: Boston Scientific</li> <li>Longitudinal Follow-Up to (1 of 2) Genetic Epidemiology of COPD. Funder: COPD Foundation</li> </ul> Clinical Investigator public 2024-06-20T13:07:39 https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/49952206/?sort=date&direction=descending